Called the draft National Intellectual Property Rights policy, this document is likely to interest President Barack Obama greatly since it could determine the size of profits that American pharmaceutical companies can make by selling medicines to Indians. Conversely, it could affect the healthcare costs of millions of Indians...At the heart of the debate is the issue of how drugs are patented.